Lead sponsor
University of Sao Paulo General Hospital
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
118
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Trials by status
Not yet recruiting
1
Active, not recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Use of Liraglutide in Children Aged 6 to 12 Years With Severe ObesityAge 6-12Ph 4Active, not recruiting30